Glomerular hyperfiltration predicts the development of microalbuminuria in stage 1 hypertension: The HARVEST

Kidney International

Volumn 70, Issue 3, 2006, Pages 578-584

  Palatini, P ^a   Mormino, P ^a   Dorigatti, F ^a   Santonastaso, M ^b   Mos, L ^a   De Toni, R ^a   Winnicki, M ^a   Follo, M Dal ^b   Biasion, T ^c   Garavelli, G ^d   Pessina, A C ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b Town Hospital   (Italy)

^c Town Hospital   (Italy)

^d Town Hospital   (Italy)

Author keywords

Ambulatory; Blood pressure; Hypertension; Prognosis

Indexed keywords

ALBUMIN;

ADULT; AGE; ARTICLE; BLOOD PRESSURE MONITORING; CONTROLLED STUDY; CREATININE CLEARANCE; FEMALE; FOLLOW UP; GENDER; GLOMERULUS FILTRATION; HUMAN; HYPERTENSION; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; MULTIVARIATE ANALYSIS; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SYSTOLIC BLOOD PRESSURE;

ADULT; ALBUMINURIA; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; HYPERTENSION, RENAL; INCIDENCE; LINEAR MODELS; MALE; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SEX DISTRIBUTION;

EID: 33746554271     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/sj.ki.5001603     Document Type: Article

References (37)

1. Chobanian AV, Bakris GL, Black HR et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289: 2560-2572.
2. Guidelines Committee. 2003 European Society of Hypertension/European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003; 21: 1011-1053.
3. Jager A, Kostense PJ, Ruhe HG et al. Microalbuminuria and peripheral arterial disease are independent predictors of cardiovascular and all-cause mortality, especially among hypertensive subjects: five-year follow-up of the Hoorn Study. Arterioscler Thromb Vasc Biol 1999; 19: 617-624.
4. Jensen JS, Feldt-Rasmussen B, Strandgard S et al. Arterial hypertension, microalbuminuria, and ischemic heart disease. Hypertension 2000; 35: 898-903.
5. Karalliedde J, Viberti G. Microalbuminuria and cardiovascular risk. Am J Hypertens 2004; 17: 986-993.
6. De Jong PE, Hillege HL, Pinto-Sietsma SJ, De Zeeuw D. Screening for microalbuminuria in the general population: a tool to detect subjects at risk for progressive renal failure in an early phase? Nephrol Dial Transplant 2003; 18: 10-13.
7. Redon J, Ruilope LM. Microalbuminuria as an intermediate endpoint in essential hypertension: evidence is coming. J Hypertens 2004; 22: 1679-1681.
8. Leoncini G, Sacchi G, Ravera M et al. Microalbuminuria is an integrated marker of subclinical organ damage in primary hypertension. J Hum Hypertens 2002; 16: 399-404.
9. Hostetter TH, Olson JL, Rennke HG et al. Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation. Am J Physiol 1981; 241: F85-F93.
10. Mogensen CE, Christensen CK. Predicting diabetic nephropathy in insulin-dependent patients. N Engl J Med 1984; 311: 89-93.
11. Dahlquist G, Aperia A, Broberger O et al. Renal function in relation to metabolic control in children with diabetes of different duration. Acta Paediatr Scand 1983; 72: 903-909.
12. Steinke JM, Sinaiko AR, Kramer MS et al. The early natural history of nephropathy in type 1 diabetes: III. Predictors of 5-year urinary albumin excretion rate patterns in initially normoalbuminuric patients. Diabetes 2005; 54: 2164-2171.
13. Redon J, Rovira E, Miralles A et al. Factors related to the occurrence of microalbuminuria during antihypertensive treatment in essential hypertension. Hypertension 2002; 39: 794-798.
14. De Jong PE, Brenner BM. From secondary to primary prevention of progressive renal disease: the case for screening for albuminuria. Kidney Int 2004; 66: 2109-2118.
15. Rudberg S, Persson B, Dahlquist G. Increased glomerular filtration rate as a predictor of diabetic nephropathy - an 8-year prospective study. Kidney Int 1992; 41: 822-828.
16. Taniwaki H, Ishimura E, Emoto M et al. Relationship between urinary albumin excretion and glomerular filtration rate in normotensive, nonproteinuric patients with type 2 diabetes mellitus. Nephron 2000; 86: 36-43.
17. Amin R, Turner C, van Aken S et al. The relationship between microalbuminuria and glomerular filtration rate in young type 1 diabetic subjects: The Oxford Regional Prospective Study. Kidney Int 2005; 68: 1740-1749.
18. Agewall S, Fagerberg B. Risk factors that predict development of microalbuminuria in treated hypertensive men. The Risk Factor Intervention Study Group. Angiology 1996; 47: 963-972.
19. Palatini P, Mormino P, Mos L et al. Microalbuminuria, renal function and development of sustained hypertension: a longitudinal study in the early stage of hypertension. J Hypertens 2005; 23: 175-182.
20. Brenner BM, Rector FC (eds). The Kidney. WB Saunders Company: Philadelphia, 2004, pp 911.
21. Premaratne E, Macisaac RJ, Tsalamandris C et al. Renal hyperfiltration in type 2 diabetes: effect of age-related decline in glomerular filtration rate. Diabetologia 2005; 48: 2486-2493.
22. Verhave JC, Hillege HL, Burgerhof JG et al. The association between atherosclerotic risk factors and renal function in the general population. Kidney Int 2005; 67: 1967-1973.
23. Remuzzi A, Viberti G, Ruggenenti P et al. Glomerular response to hyperglycemia in human diabetic nephropathy. Am J Physiol 1990; 259: F545-F552.
24. Jin Y, Moriya T, Tanaka K et al. Glomerular hyperfiltration in nonproteinuric and non-hypertensive Japanese type 2 diabetic patients. Diabetes Res Clin Pract 2006; 71: 264-271.
25. Brenner BM, Chertow GM. Congenital oligonephropathy and the etiology of adult hypertension and progressive renal injury. Am J Kidney Dis 1994; 23: 171-175.
26. Nosadini R, Semplicini A, Fioretto P et al. Sodium-lithium countertransport and cardiorenal abnormalities in essential hypertension. Hypertension 1991; 18: 191-198.
27. + transport and atrial natriuretic peptide. J Nephrol 2002; 15: 489-496.
28. Oparil S, Weber MA. Hypertension, 2nd edn. Elsevier-Saunders: China, 2005.
29. Ruggenenti P, Fassi A, Ilieva AP et al. Preventing microalbuminuria in type 2 diabetes. N Engl J Med 2004; 351: 1941-1951.
30. De Paula RB, Da Silva AA, Hall JE. Aldosterone antagonism attenuates obesity-induced hypertension and glomerular hyperfiltration. Hypertension 2004; 43: 41-47.
31. Ribstein G, Du Cailar G, Fesler P, Mimran A. Relative glomerular hyperfiltration in primary aldosteronism. J Am Soc Nephrol 2005; 16: 1320-1325.
32. Palatini P, Graniero G, Mormino P et al. Relation between physical training and ambulatory blood pressure in stage I hypertensive subjects. Results of the HARVEST trial. Circulation 1994; 90: 2870-2876.
33. Sartori M, Semplicini A, Siffert W et al. G-protein beta3-subunit gene 825T allele and hypertension: a longitudinal study in young grade I hypertensives. Hypertension 2003; 42: 909-914.
34. Pinto-Sietsma SJ, Janssen WMT, Hillege HL et al. Urinary albumin excretion is associated with renal functional abnormalities in a nondiabetic population. J Am Soc Nephrol 2000; 11: 1882-1888.
35. Treating mild hypertension. Report of the British Hypertension Society working party. BMJ 1989; 298: 694-698.
36. 1999 World Health Organization - International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Subcommittee. J Hypertens 1999; 17: 151-183.
37. O'Brien E, Asmar R, Beilin L et al. European Society of Hypertension Working Group on Blood Pressure Monitoring. European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement. J Hypertens 2003; 21: 821-848.